Clinical research - Press Releases

Date	Title	Company
26-Jan-2023	Pistoia Alliance Publishes Free Guide to Accelerate the Implementation of FAIR Principles in Clinical Data	Pistoia Alliance
26-Jan-2023	NETRIS Pharma Doses First Patient in Hepatocellular Carcinoma (HCC) Clinical Study with NP137	NETRIS Pharma
25-Jan-2023	Blackford and Brainomix Announce AI Partnership for Stroke Care	Blackford and Brainomix
25-Jan-2023	First Provider in Germany: CeGaT Offers Sequencing Services Based on PacBio's SMRT Technology	CeGaT
25-Jan-2023	Sosei Heptares Webinar Presentation for FY2022 Financial Results	Sosei Heptares
25-Jan-2023	STORM Therapeutics Presents STC-15 Preclinical Data Supporting Treatment of Patients with AML at the AACR Acute Myeloid Leukemia and Myelodysplastic Syndrome Conference	STORM Therapeutics
25-Jan-2023	Cell Therapy Market is estimated to be US$ 19.6 billion by 2030 with a CAGR of 13.1% during the forecast period	prophecy
25-Jan-2023	Organic Acids Market is estimated to be US$ 18.6 billion by 2032 with a CAGR of 6.8% over the forecast period (2022-2032)	Prophecy Market Insights
24-Jan-2023	Velocity announces three leadership hires in Europe	Velocity Clinical Research
19-Jan-2023	AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease	AC Immune
19-Jan-2023	Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®) In Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer at 2023 ASCO Gastrointestinal Cancers Symposium	Servier and Taiho Oncology
18-Jan-2023	Positive Interim Results from DFU Clinical Study & Burn Clinical Study Update	Spectral MD Holdings, Ltd.
17-Jan-2023	SolasCure announces publication of toxicology and pre-clinical research programme as final patient is enrolled into pivotal clinical trial	SolasCure
17-Jan-2023	ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002	ImmunOs Therapeutics
11-Jan-2023	HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)	HighTide Therapeutics Inc.
11-Jan-2023	Ethics Approval granted for significant Ultra Pure Synthetic CBD Phase III Efficacy Clinical Trial	Chanelle McCoy Health
10-Jan-2023	Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities	Symeres
10-Jan-2023	Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark	Phastar
09-Jan-2023	Quanticate makes key appointment to bolster leadership team	Quanticate
06-Jan-2023	Egnyte to provide early-stage life science startups a year of Egnyte’s platform at no cost	Egnyte